VISTAR HOLDINGS (08535) temporarily suspended from October 16 pending publication of inside information
VISTAR HOLDINGS (08535) announces that at the request of the Company, trading in the shares of the Company on The Stock Exchange of Hong Kong Limited has been temporarily suspended with effect from 9:00 a.m. on Friday, October 16, 2026, pending the publication of an announcement in accordance with the Codes on Takeovers and Mergers, the contents of which constitute inside information of the Company.
VISTAR HOLDINGS (08535) announced that at the request of the Company, trading in the Company's shares on The Stock Exchange of Hong Kong Limited has been temporarily suspended with effect from 9:00 a.m. on Friday, October 16, 2026, pending the publication of an announcement pursuant to the Code on Takeovers and Mergers, the contents of which constitute inside information of the Company.
Related Articles
HK Stock Market Move | Biocytogen Pharmaceuticals-B (02315) surged over 6% in early trading; its model animal business delivered strong performance in the first half of the year, and the company continues to develop innovative animal models.
A-share Market Opening Brief | All three major indices open higher, with pharmaceuticals and computing power hardware leading gains
HK Stock Market Move | KEYMED BIO-B (02162) Surges Over 12% as Kangyueda Revenue for the First Three Quarters Increased 227% Year-on-Year and New Indication Approved
HK Stock Market Move | Biocytogen Pharmaceuticals-B (02315) surged over 6% in early trading; its model animal business delivered strong performance in the first half of the year, and the company continues to develop innovative animal models.
A-share Market Opening Brief | All three major indices open higher, with pharmaceuticals and computing power hardware leading gains
HK Stock Market Move | KEYMED BIO-B (02162) Surges Over 12% as Kangyueda Revenue for the First Three Quarters Increased 227% Year-on-Year and New Indication Approved
